electroCore Revenue and Competitors
Estimated Revenue & Valuation
- electroCore's estimated annual revenue is currently $4.9M per year.
- electroCore received $70.0M in venture funding in November 2017.
- electroCore's estimated revenue per employee is $62,692
- electroCore's total funding is $145.5M.
- electroCore's current valuation is $50.8M. (January 2022)
Employee Data
- electroCore has 78 Employees.
- electroCore grew their employee count by 10% last year.
electroCore Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.8M | 20 | -13% | N/A | N/A |
#2 | $8.8M | 43 | 54% | N/A | N/A |
#3 | $4.9M | 40 | 3% | N/A | N/A |
#4 | $4M | 31 | 0% | N/A | N/A |
#5 | $1.8M | 7 | N/A | N/A | N/A |
#6 | $267.6M | 914 | 8% | N/A | N/A |
#7 | $3.1M | 24 | -4% | N/A | N/A |
#8 | $3M | 24 | 4% | N/A | N/A |
#9 | $11.5M | 41 | 5% | N/A | N/A |
#10 | $400.8M | 1332 | 5% | N/A | N/A |
What Is electroCore?
In 2005, we were founded on a unified belief that neuromodulation could be used in novel ways to help patients break free from treatments they aren't happy with. Because different modalities of neuromodulation had previously proven to be effective and safe, we recognized an opportunity to be the leader in this new frontier of medicine and took it head on. Our mission is simplehelp patients across the globe who suffer from pain and chronic conditions. We are doing this by harnessing the power of nVNS, innovation, and technology to develop safe and clinically backed treatments. Bringing new treatments to market will help improve patients' treatment options and lives.
keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals
$145.5M
Total Funding
78
Number of Employees
$4.9M
Revenue (est)
10%
Employee Growth %
$50.8M
Valuation
N/A
Accelerator
electroCore News
ROCKAWAY, N.J., April 21, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company,...
electroCore, Inc. (NASDAQ:ECOR) Expected to Announce Earnings of -$0.05 Per Share. Posted by admin on Apr 19th, 2022.
electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance. April 12, 2022 08:00 ET | Source: electroCore, Inc. electroCore, Inc.
electroCore, a Basking Ridge, NJ-based bioelectronic medicine healthcare company,, completed an over $70m Series B financing. The round was led by Core Ventures II, with participation from Merck’s Global Health Innovation Fund, Gakasa, American Investment Holdings LLC and the Vinik Family Found ...
Other Companies in Basking Ridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.9M | 81 | 1% | N/A |
#2 | $7.5M | 83 | 8% | N/A |
#3 | $13.1M | 87 | 4% | N/A |
#4 | $35M | 87 | N/A | N/A |
#5 | $10.9M | 89 | 17% | N/A |
electroCore Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-07-02 | $50.0M | Undisclosed | Merck s Global Health Innovation Fund | Article |
| 2016-08-09 | $1.5M | Undisclosed | Article | |
| 2017-09-11 | $36.0M | Undisclosed | Article | |
| 2017-11-30 | $70.0M | B | Core Ventures II | Article |
electroCore Executives
| Name | Title |
|---|---|
| Peter Staats | Chief Medical Officer |
| Dan Goldberger | CEO and Director |
| Dan Duhart | Chief Commercial Officer (CCO) |
| Bruce Simon | VP Research |
| Eric Liebler | SVP; Neurology |
| Michael Romaniw | Executive Vice President, Systems & Operations |
| Iain Strickland | Vice President European Operations |
| Mitch DeShon | Vice President US Sales |
| Jacquelyn Dorsky | Vice President, Marketing |
| Libby Cerullo | VP RA/CA |
| Basit Qari | VP/Head of Information and Digital Technologies |
| Bruce Simon | Vice President of Research |
| Joshua Lev | Vice President, Business Development, Strategy, and FP&A |
| Iain Strickland | Senior Vice President, Global Sales and Strategy |